Include All CSL Behring Country Sites
With cutting-edge facilities, technologies and technical expertise, Seqirus will be a reliable supplier of seasonal influenza vaccine with the ability to rapidly respond to pandemic threats.
Read More >
Welcome to Seqirus
In July 2015, bioCSL and the influenza vaccines of Novartis joined forces to create Seqirus, now the second ...
Seqirus donates vaccines to Fiji to alleviate increase in influenza
20,000 doses of seasonal influenza vaccine to ...
FDA approval for FLUCELVAX QUADRIVALENT™ (Influenza Vaccine) for people four years of age and older
The first four-strain, cell culture-derived, ...
Seqirus Honored with National Award for Outstanding Efforts in Influenza Prevention
#KnockOutFlu Campaign Drove Home the Importance ...
© 2016 Seqirus